Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) SHH

Currency In CNY

AD

Valuation

Market Cap11.67B
Enterprise Value11.41B
P/E Ratio30.98
PEG Ratio-0.95
Price/Sales Ratio5.31
Price/Book Ratio2.83
Enterprise/Revenue5.52
Enterprise/EBITDA22.01

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.17
Operating Margin0.19
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue1.48B
Revenue/Share7.85
Gross Profit1.48B
EBITDA417.66M
Net Income268.17M
Diluted EPS1.4

Balance Sheet

Total Cash728.83M
Total Cash/Share3.76
Total Debt979.96M
Total Debt/Equity0.34
Current Ratio3.11
Book Value Per Share16.11

Price History

52-Week Change-45.93
52-Week High83.83
52-Week Low35.23
Moving Average 50 Days40.7
Moving Average 200 Days53.94

Statistics

Average Volume3.24M
Shares Outstanding193.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.32
Trailing Annual Dividend Yield0.77
Payout Ratio0.06
Last Split Factor9:5
Last Split DateJune 05, 2024
AD